PCA
GILD icon

Pallas Capital Advisors’s Gilead Sciences GILD Stock Holding History

Pallas Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
7,558
-1,379
-15% -$193K 0.04% 318
2025
Q4 		$1.1M Buy
8,937
+91
+1% +$11.1K 0.04% 341
2025
Q3 		$982K Buy
8,846
+137
+2% +$15.6K 0.04% 350
2025
Q2 		$966K Buy
8,709
+869
+11% +$92.5K 0.04% 339
2025
Q1 		$878K Sell
7,840
-310
-4% -$32K 0.04% 321
2024
Q4 		$753K Buy
8,150
+314
+4% +$28.3K 0.03% 294
2024
Q3 		$696K Buy
7,836
+2,069
+36% +$158K 0.03% 293
2024
Q2 		$424K Buy
5,767
+2,665
+86% +$178K 0.02% 342
2024
Q1 		$227K Buy
+3,102
New +$239K 0.01% 395

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pallas Capital Advisors's GILD Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $193K and leaving 7,558 shares worth $1.05M. The position accounts for 0.04% of the portfolio, ranked #318.

Pallas Capital Advisors first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.1M in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Pallas Capital Advisors held 7,558 shares of Gilead Sciences worth $1.05M as of Q1 2026.
  • Pallas Capital Advisors sold 1,379 Gilead Sciences shares in Q1 2026, an estimated $193K.
  • Gilead Sciences made up 0.04% of Pallas Capital Advisors's portfolio in Q1 2026, its #318 holding.
  • Pallas Capital Advisors first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
  • Pallas Capital Advisors's Gilead Sciences position peaked at $1.1M in Q4 2025.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.